Jain RK et al. (2006) Lessons from phase III clinical trials on anti-VEGF therapy for cancer
1
Jain RK et al. (2006) Lessons from phase III clinical trials on anti-VEGF therapy for cancer Nat Clin Pract Oncol 3: 24–40 doi:10.1038/ncponc0403 Table 3 Completed Phase III trials for multi-targeted agents with VEGF receptor 2 kinase as one of their targets
-
Upload
veda-giles -
Category
Documents
-
view
18 -
download
2
description
Table 3 Completed Phase III trials for multi-targeted agents with VEGF receptor 2 kinase as one of their targets. Jain RK et al. (2006) Lessons from phase III clinical trials on anti-VEGF therapy for cancer Nat Clin Pract Oncol 3: 24 –40 doi:10.1038/ncponc0403. - PowerPoint PPT Presentation
Transcript of Jain RK et al. (2006) Lessons from phase III clinical trials on anti-VEGF therapy for cancer
Jain RK et al. (2006) Lessons from phase III clinical trials on anti-VEGF therapy for cancerNat Clin Pract Oncol 3: 24–40 doi:10.1038/ncponc0403
Table 3 Completed Phase III trials for multi-targeted agents with VEGF receptor 2 kinase as one of their targets
